ATHANASIOU DIMITRIOS retweeted
We waited far too long for the results of the For-DMD study, but here they are: jamanetwork.com/journals/jam…
ATHANASIOU DIMITRIOS retweeted
September 7 is World Duchenne Awareness Day: Spreading Duchenne Muscular Dystrophy Awareness https://nitter.cf/t.co/mXCycmfyy7 #DuchenneMuscularDystrophy #WDAD2021 #RareDisease @worldduchenne
ATHANASIOU DIMITRIOS retweeted
.@VitalTransform is proud to be supporting the 1st Int Conference on Rare Diseases:
“Building a Pathway from Diagnosis to Access”
1-2 March 2021
Info & Registration -> https://nitter.cf/t.co/X5IsY9qSKp
#rarediseasesconference21
ATHANASIOU DIMITRIOS retweeted
Novartis has sold 100 lots of its gene therapy for spinal muscular atrophy so far this year at $1.75 million a shot. Not much uptake for annual payments. This is a disease with no other treatment. I do not believe these data will apply to #hemophilia. tiny.cc/cyozez
ATHANASIOU DIMITRIOS retweeted
When the medicine your child needs is priced too high for the NHS what do you do?
#CFBuyersClub #OrkambiNow bbc.co.uk/news/health-483577…
ATHANASIOU DIMITRIOS retweeted
Delighted to see strong media coverage of our new study across Europe
At a glance, here's how Europe's top 30 medical universities performed on #clinicaltrials transparency
transparimed.org/single-post…
ATHANASIOU DIMITRIOS retweeted
Three questions yesterday @EFPIA dinner:
1 What does #EU contribute to #health & care?
2 Are we adding the maximum value to #patients, families, & healthcare workers?
3 Can we do more to lessen the burden on health systems today & in the future?
Answers 👉europa.eu/!bQ79GB
ATHANASIOU DIMITRIOS retweeted
#FDA officials see 'missed opportunity' with patient outcomes in clinical trials: FDA has shown an interest in PROs,: The information is seen as a valuable tool for improving clinical trial designs, guiding drug approvals & supporting label decisions.
biopharmadive.com/news/fda-o…
ATHANASIOU DIMITRIOS retweeted
Read my profile in Muscular Dystrophy News Today on how #Duchenne affects one #Greek family. @ParentProjectMD #endDuchenne @DuchenneUK @MitchelsJourney @mdahellas @uppmdduchenne https://nitter.cf/t.co/k3npIVXCFK
ATHANASIOU DIMITRIOS retweeted
The new platform for paediatric rare diseases has arrived! Check out the new website here: share4rare.org 🚀 Big thanks to @omada_int @Melanoma_MRV @worldduchenne @la_UPC @SJDbarcelona_es @The_Synergist 💜 #CitizenScience #S4R_eu #PatientEngagement #Live #WebsiteLaunch
ATHANASIOU DIMITRIOS retweeted
Vamorolone progress cofunded by foundations @ParentProjectMD @mdausa @DuchenneUK @alljoinjack @duchennemd @SOSsaveoursons @ActionDuchenne @CureDuchenne @RyansQuestOrg @alexswish @PietrosFight @Michaelscause1 @DuchenneRF nitter.cf/vision_dmd/status/1011…
Replying to @ReveraGen
@ReveraGen release details of vision-dmd phase 2a study vision-dmd.info/vision1/wp-c… Eric Hoffman will present @ParentProjectMD Pls RT @worldduchenne @trinds_nmd @TREAT_NMD
ATHANASIOU DIMITRIOS retweeted
#ppmdconference there was mention about the FDA being prepared to extrapolate from trial populations to wider populations. The EMA seems less so, as well as payers. How can we address this with pharma?
ATHANASIOU DIMITRIOS retweeted
#EMA carried out a total of 925 activities involving #patients and 445 activities involving #HealthcareProfessionals during 2017. Read more in our latest Stakeholder Engagement report: https://nitter.cf/t.co/g6x8v4koFs
ATHANASIOU DIMITRIOS retweeted
📣Make sure to register at the best rate! 2 days left to benefit from Early Bird rates for the Joint #EFGCP & @DrugInfoAssn Better Medicines for Children Conference: efgcp.eu/cgi?lg=en&pag=3846&… #Paediatrics2018
ATHANASIOU DIMITRIOS retweeted
Only a few days left before our new community-based platform is launched, dedicated to rare disease patients and families. We're thrilled to see this collaboration project getting shape! 💜 #FinalCountdown #CollectiveIntelligence #RareDiseases #S4R_eu #YouAreNotAlone
ATHANASIOU DIMITRIOS retweeted
#RareDiseases are sexy" when it comes to the potential for profit, says #Greek financial consultant Dimitris Athanasiou, whose son has #Duchenne. Read my story in #Muscular Dystrophy News Today. @CureDuchenne @ParentProjectMD @uppmdduchenne @ExonicsTx https://nitter.cf/t.co/ZsVMjOzJe2
ATHANASIOU DIMITRIOS retweeted
Dr. Eric Olson w gene editing revolutionizing the therapy/lives of hundreds of thousands Duchenne’s Muscular Dystrophy patients!Inspiring keynote at CV Medicine Olympiad in Athens, Greece! @UTSWNews @UofUHealth @DuchenneUK @ActionDuchenne @josephahill @CureDuchenne @CoalitionDMD – at Attiki, Greece
ATHANASIOU DIMITRIOS retweeted
Students "it's important to be involved as patients in medicines development" @pain_europe @eupatients #eupati2015 – at Dublin City, Ireland
ATHANASIOU DIMITRIOS retweeted
Some #EUPATI2015 ambassadors! :-)






























